A study by Zhang et al. [100] showed that dexprami prevents lipopolysaccharide-induced neuroinflammation and cognitive impairments by protecting mitochondria and inhibiting the pyroptotic signal via inhibiting NLRP3 and caspase-1. The gene discussed is CASP1; the disease is Cognitive impairment.